Interleukin-33 promotes inflammatory cytokine production in chronic airway inflammation

Biochemistry and Cell Biology

Volumn 93, Issue 4, 2015, Pages 359-366

  Zhao, Jianping ^a   Shang, Jin ^a   Zhao, Junling ^a   Wu, Xiaojie ^a   Xu, Yongjian ^a   Xie, Jungang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Chronic obstructive pulmonary disease; Cigarette smoke extract; Human bronchial epithelial; Interleukin 33; Peripheral blood mononuclear cell

Indexed keywords

BLOOD; CELLS; CYTOLOGY; INTERFERONS; PATHOLOGY; PULMONARY DISEASES; TOBACCO;

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CIGARETTE SMOKES; HUMAN BRONCHIAL EPITHELIAL; INTERLEUKIN-33; PERIPHERAL BLOOD MONONUCLEAR CELLS;

CELL SIGNALING;

CIGARETTE SMOKE; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN 33; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P42; PROTEIN P44; AUTACOID; CYTOKINE;

ADULT; AGED; ARTICLE; BRONCHUS MUCOSA; CHRONIC AIRWAY INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MALE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; BIOSYNTHESIS; BRONCHITIS; CELL LINE; METABOLISM; PHYSIOLOGY; RANDOMIZATION;

AGED; BRONCHITIS; CELL LINE; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-33; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOM ALLOCATION;

EID: 84937845378     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/bcb-2014-0163     Document Type: Article

References (43)

1. Ali S. Huber M. Kollewe C. Bischoff S.C. Falk W. Martin M.U. 2007. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc. Natl. Acad. Sci. U.S.A. 104 (47): 18660-18665. 10.1073/pnas.0705939104. 18003919.
2. Allakhverdi Z. Smith D.E. Comeau M.R. Delespesse G. 2007. Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J. Immunol. 179 (4): 2051-2054. 10.4049/jimmunol.179.4.2051. 17675461.
3. Baraldo S. Turato G. Badin C. Bazzan E. Beghe B. Zuin R. et al 2004. Neutrophilic infiltration within the airway smooth muscle in patients with COPD. Thorax, 59 (4): 308-312. 10.1136/thx.2003.012146. 15047950.
4. Barczyk A. Pierzchala W. Kon O.M. Cosio B. Adcock I.M. Barnes P.J. 2006. Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 117 (6): 1484-1492. 10.1016/j.jaci.2006.02.013. 16751017.
5. Byers D.E. Alexander-Brett J. Patel A.C. Agapov E. Dang-Vu G. Jin X. et al 2013. Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J. Clin. Invest. 123 (9): 3967-3982. 10.1172/JCI65570. 23945235.
6. Cayrol C. Girard J.P. 2009. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl. Acad. Sci. U.S.A. 106 (22): 9021-9026. 10.1073/pnas.0812690106. 19439663.
7. Chackerian A.A. Oldham E.R. Murphy E.E. Schmitz J. Pflanz S. Kastelein R.A. 2007. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J. Immunol. 179 (4): 2551-2555. 10.4049/jimmunol.179.4.2551. 17675517.
8. Chen S.F. Nieh S. Jao S.W. Wu M.Z. Liu C.L. Chang Y.C. Lin Y.S. 2013. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma. J. Pathol. 231 (2): 180-189. 10.1002/path.4226. 23775566.
9. Chen Y. Huang P. Ai W. Li X. Guo W. Zhang J. et al 2012. Histone deacetylase activity is decreased in peripheral blood monocytes in patients with COPD. J. Inflamm. (Lond.), 9: 10. 10.1186/1476-9255-9-10. 22443498.
10. Cherry W.B. Yoon J. Bartemes K.R. Iijima K. Kita H. 2008. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J. Allergy Clin. Immunol. 121 (6): 1484-1490. 10.1016/j.jaci.2008.04.005. 18539196.
11. Clarke D. Damera G. Sukkar M.B. Tliba O. 2009. Transcriptional regulation of cytokine function in airway smooth muscle cells. Pulm. Pharmacol. Ther. 22 (5): 436-445. 10.1016/j.pupt.2009.04.003. 19393330.
12. Dancer R. Sansom D.M. 2013. Regulatory T cells and COPD. Thorax, 68 (12): 1176-1178. 10.1136/thoraxjnl-2013-203878. 24149825.
13. de Boer W.I. Sont J.K. van Schadewijk A. Stolk J. van Krieken J.H. Hiemstra P.S. 2000. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J. Pathol. 190 (5): 619-626. 10.1002/(SICI)1096-9896(200004)190:5<619::AID-PATH555>3.0.CO;2-6. 10727989.
14. Dhillon A.S. Hagan S. Rath O. Kolch W. 2007. MAP kinase signalling pathways in cancer. Oncogene, 26 (22): 3279-3290. 10.1038/sj.onc.1210421. 17496922.
15. Dinarello C.A. 2005. An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor. Immunity, 23 (5): 461-462. 10.1016/j.immuni.2005.10.004. 16286013.
16. Hoebe K. Janssen E. Beutler B. 2004. The interface between innate and adaptive immunity. Nat. Immunol. 5 (10): 971-974. 10.1038/ni1004-971. 15454919.
17. Hogg J.C. 2004. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet, 364 (9435): 709-721. 10.1016/S0140-6736(04)16900-6. 15325838.
18. Hudson C.A. Christophi G.P. Gruber R.C. Wilmore J.R. Lawrence D.A. Massa P.T. 2008. Induction of IL-33 expression and activity in central nervous system glia. J. Leukoc. Biol. 84 (3): 631-643. 10.1189/jlb.1207830. 18552204.
19. Iikura M. Suto H. Kajiwara N. Oboki K. Ohno T. Okayama Y. et al 2007. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab. Invest. 87 (10): 971-978. 10.1038/labinvest.3700663. 17700564.
20. Kamijo S. Takeda H. Tokura T. Suzuki M. Inui K. Hara M. et al 2013. IL-33-mediated innate response and adaptive immune cells contribute to maximum responses of protease allergen-induced allergic airway inflammation. J. Immunol. 190 (9): 4489-4499. 10.4049/jimmunol.1201212. 23547117.
21. Karadag F. Karul A.B. Cildag O. Yilmaz M. Ozcan H. 2008. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Lung, 186 (6): 403-409. 10.1007/s00408-008-9106-6. 18807087.
22. Lee K.E. Kim K.W. Hong J.Y. Kim K.E. Sohn M.H. 2013. Modulation of IL-8 boosted by Mycoplasma pneumoniae lysate in human airway epithelial cells. J. Clin. Immunol. 33 (6): 1117-1125. 10.1007/s10875-013-9909-y. 23779254.
23. Lin J. Zhang L. Zhao G. Su Z. Deng R. Pflugfelder S.C. Li D.Q. 2013. A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium. PLoS One, 8 (4): e60963. 10.1371/journal.pone.0060963. 23585867.
24. Mat Z. Grensemann B. Yakin Y. Knobloch J. Koch A. 2012. Effect of lipoteichoic acid on IL-2 and IL-5 release from T lymphocytes in asthma and COPD. Int. Immunopharmacol. 13 (3): 284-291. 10.1016/j.intimp.2012.04.005. 22542695.
25. Moussion C. Ortega N. Girard J.P. 2008. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel "alarmin"? PLoS One, 3 (10): e3331. 10.1371/journal.pone.0003331. 18836528.
26. O'Donnell R.A. Peebles C. Ward J.A. Daraker A. Angco G. Broberg P. et al 2004. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax, 59 (10): 837-842. 10.1136/thx.2003.019349. 15454648.
27. Pace E. Di Sano, C. Sciarrino S. Scafidi V. Ferraro M. Chiappara G. et al 2014. Cigarette smoke alters IL-33 expression and release in airway epithelial cells. Biochim. Biophys. Acta, 1842 (9): 1630-1637. 10.1016/j.bbadis.2014.06.009. 24931101.
28. Palmer G. Lipsky B.P. Smithgall M.D. Meininger D. Siu S. Talabot-Ayer D. et al 2008. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. Cytokine, 42 (3): 358-364. 10.1016/j.cyto.2008.03.008. 18450470.
29. Qiu C. Li Y. Li M. Li M. Liu X. McSharry C. et al 2013. Anti-interleukin-33 inhibits cigarette smoke-induced lung inflammation in mice. Immunology, 138 (1): 76-82. 10.1111/imm.12020. 23078031.
30. Rabe K.F. Hurd S. Anzueto A. Barnes P.J. Buist S.A. Calverley P. et al 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 176 (6): 532-555. 10.1164/rccm.200703-456SO. 17507545.
31. Rutgers S.R. Postma D.S. ten Hacken N.H. Kauffman H.F. van Der Mark T.W. Koeter G.H. et al 2000. Ongoing airway inflammation in patients with COPD who Do not currently smoke. Chest, 117 (5 Suppl. 1): 262S. 10.1378/chest.117.5-suppl-1.262S. 10843943.
32. Schild K. Knobloch J. Yakin Y. Jungck D. Urban K. Muller K. et al 2011. IL-5 release of CD4+ non-effector lymphocytes is increased in COPD-modulating effects of moxifloxacin and dexamethasone. Int. Immunopharmacol. 11 (4): 444-448. 10.1016/j.intimp.2010.12.013. 21215348.
33. Schmitz J. Owyang A. Oldham E. Song Y. Murphy E. McClanahan T.K. et al 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity, 23 (5): 479-490. 10.1016/j.immuni.2005.09.015. 16286016.
34. Smithgall M.D. Comeau M.R. Yoon B.R. Kaufman D. Armitage R. Smith D.E. 2008. IL-33 amplifies both Th1-and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int. Immunol. 20 (8): 1019-1030. 10.1093/intimm/dxn060. 18550585.
35. Sponheim J. Pollheimer J. Olsen T. Balogh J. Hammarstrom C. Loos T. et al 2010. Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am. J. Pathol. 177 (6): 2804-2815. 10.2353/ajpath.2010.100378. 21037074.
36. Turato G. Zuin R. Miniati M. Baraldo S. Rea F. Beghe B. et al 2002. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. Am. J. Respir. Crit. Care Med. 166 (1): 105-110. 10.1164/rccm.2111084. 12091179.
37. Wouters E.F. Groenewegen K.H. Dentener M.A. Vernooy J.H. 2007. Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc. Am. Thorac. Soc. 4 (8): 626-634. 10.1513/pats.200706-071TH. 18073394.
38. Wouters E.F. Reynaert N.L. Dentener M.A. Vernooy J.H. 2009. Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection? Proc. Am. Thorac. Soc. 6 (8): 638-647. 10.1513/pats.200907-073DP. 20008867.
39. Wu H. Yang S. Wu X. Zhao J. Zhao J. Ning Q. et al 2014. Interleukin-33/ST2 signaling promotes production of interleukin-6 and interleukin-8 in systemic inflammation in cigarette smoke-induced chronic obstructive pulmonary disease mice. Biochem. Biophys. Res. Commun. 450 (1): 110-116. 10.1016/j.bbrc.2014.05.073. 24866242.
40. Xia J. Zhao J. Shang J. Li M. Zeng Z. Wang J. et al 2015. Increased IL-33 expression in chronic obstructive pulmonary disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 308 (7): L619-L627. 10.1152/ajplung.00305.2014. 25595648.
41. Xie J. Zhao J. Xiao C. Xu Y. Yang S. Ni W. 2010. Reduced heat shock protein 70 in airway smooth muscle in patients with chronic obstructive pulmonary disease. Exp. Lung Res. 36 (4): 219-226. 10.3109/01902140903349562. 20426530.
42. Yagami A. Orihara K. Morita H. Futamura K. Hashimoto N. Matsumoto K. et al 2010. IL-33 mediates inflammatory responses in human lung tissue cells. J. Immunol. 185 (10): 5743-5750. 10.4049/jimmunol.0903818. 20926795.
43. Zhang K. Shan L. Rahman M.S. Unruh H. Halayko A.J. Gounni A.S. 2007. Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 293 (2): L375-L382. 10.1152/ajplung.00045.2007. 17513456.